AstraZeneca COVID-19 Vaccine Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04864561COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222
NCT05188677Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults
NCT05715944Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2